Since its recognition by WHO in 2004, the diagnosis of TFE3-rearranged renal cell carcinoma (RCC) relied on microscopic appearance and TFE3 IHC. This evidence concerns the gene TFE3 and hereditary clear cell renal cell carcinoma.